Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.
Alkem Laboratories Limited (ALKEM) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The ALKEM share price is ₹5,297.00 (+2.06% today), with a market capitalisation of ₹633B and a price-to-earnings (P/E) ratio of 29.4. MarketRipple tracks the ALKEM investment thesis, the ripple-chain impact of market events on Alkem Laboratories Limited, and the Healthcare sector outlook.
Open
₹5,186.50
High
₹5,297.00
Low
₹5,141.00
Prev. Close
₹5,190.00
52W High
₹5,933.50
52W Low
₹4,811.00
Day range
₹5,141.00–₹5,297.00
52-week range
₹4,811.00–₹5,933.50
Volume
65K
P/E
29.4
ROE
16.7%
D/E
0.15
Margin
14.3%
Alkem Laboratories Limited (NSE: ALKEM) is currently trading at ₹5,297.00 (+2.06%).
Alkem Laboratories Limited's market capitalization is ₹633B.
Alkem Laboratories Limited's price-to-earnings (P/E) ratio is 29.4.
Alkem Laboratories Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Alkem Laboratories Limited currently reads neutral, based on 20 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.